Chamberlain, Jeffrey S.
University of Washington
16 papers on CoChatORCID 0000-0001-5299-0059
Most cited papers
- Verified
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
Gregorevic, P., Blankinship, M. J., Allen, J. M., Crawford, R. W., Meuse, L., Miller, D. G., Russell, D. W., & Chamberlain, J. S. (2004) · Nature Medicine
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 620
- Verified
Animal models for muscular dystrophy show different patterns of sarcolemmal disruption
Straub, V., Rafael, J. A., Chamberlain, J. S., & Campbell, K. P. (1997) · The Journal of Cell Biology
Muscle Physiology and DisordersCardiomyopathy and Myosin Studies
Cited by 488
- Verified
High levels of AAV vector integration into CRISPR-induced DNA breaks
Hanlon, K. S., Kleinstiver, B. P., Garcia, S. P., Zaborowski, M. P., Volak, A., Spirig, S. E., Muller, A., Sousa, A. A., Tsai, S. Q., Bengtsson, N. E., et al. (2019) · Nature Communications
Virus-based gene therapy researchCRISPR and Genetic Engineering
Cited by 431
- Verified
Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy
Bengtsson, N. E., Hall, J. K., Odom, G. L., Phelps, M. P., Andrus, C. R., Hawkins, R. D., Hauschka, S. D., Chamberlain, J. R., & Chamberlain, J. S. (2017) · Nature Communications
CRISPR and Genetic EngineeringVirus-based gene therapy research
Cited by 387
- Verified
Cas9 immunity creates challenges for CRISPR gene editing therapies
Crudele, J. M., & Chamberlain, J. S. (2018) · Nature Communications
CRISPR and Genetic EngineeringVirus-based gene therapy research
Cited by 259
- Verified
Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle
Salva, M. Z., Himeda, C. L., Tai, P. W., Nishiuchi, E., Gregorevic, P., Allen, J. M., Finn, E. E., Nguyen, Q. G., Blankinship, M. J., Meuse, L., et al. (2007) · Molecular Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 232
- Verified
Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors
Lai, Y., Yue, Y., Liu, M., Ghosh, A., Engelhardt, J. F., Chamberlain, J. S., & Duan, D. (2005) · Nature Biotechnology
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 224
- Verified
Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin
Winbanks, C. E., Weeks, K. L., Thomson, R. E., Sepulveda, P. V., Beyer, C., Qian, H., Chen, J. L., Allen, J. M., Lancaster, G. I., Febbraio, M. A., et al. (2012) · Journal of Cell Biology
Muscle Physiology and DisordersTGF-β signaling in diseases
Cited by 218
- Verified
Adeno-Associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury
Liu, M., Yue, Y., Harper, S. Q., Grange, R. W., Chamberlain, J. S., & Duan, D. (2005) · Molecular Therapy
Virus-based gene therapy researchMuscle Physiology and Disorders
Cited by 178
- Verified
Systemic Microdystrophin Gene Delivery Improves Skeletal Muscle Structure and Function in Old Dystrophic mdx Mice
Gregorevic, P., Blankinship, M. J., Allen, J. M., & Chamberlain, J. S. (2008) · Molecular Therapy
Virus-based gene therapy researchMuscle Physiology and Disorders
Cited by 120
- Verified
Skeletal Muscle Contractions Induce Acute Changes in Cytosolic Superoxide, but Slower Responses in Mitochondrial Superoxide and Cellular Hydrogen Peroxide
Pearson, T., Kabayo, T., Ng, R., Chamberlain, J., McArdle, A., & Jackson, M. J. (2014) · PLoS ONE
Exercise and Physiological ResponsesRedox biology and oxidative stress
Cited by 107
- Verified
Gene Therapy of mdx Mice With Large Truncated Dystrophins Generated by Recombination Using rAAV6
Odom, G. L., Gregorevic, P., Allen, J. M., & Chamberlain, J. S. (2011) · Molecular Therapy
Virus-based gene therapy researchNeurogenetic and Muscular Disorders Research
Cited by 95
- Verified
Integrated expression analysis of muscle hypertrophy identifies Asb2 as a negative regulator of muscle mass
Davey, J. R., Watt, K. I., Parker, B. L., Chaudhuri, R., Ryall, J. G., Cunningham, L., Qian, H., Sartorelli, V., Sandri, M., Chamberlain, J., et al. (2016) · JCI Insight
Muscle Physiology and DisordersTGF-β signaling in diseases
Cited by 51
- Verified
Loss of niche-satellite cell interactions in syndecan-3 null mice alters muscle progenitor cell homeostasis improving muscle regeneration
Pisconti, A., Banks, G. B., Babaeijandaghi, F., Betta, N. D., Rossi, F. M. V., Chamberlain, J. S., & Olwin, B. B. (2016) · Skeletal Muscle
Muscle Physiology and DisordersNeurogenetic and Muscular Disorders Research
Cited by 50
- Verified
Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature
Gregorevic, P., Schultz, B. R., Allen, J. M., Halldorson, J. B., Blankinship, M. J., Meznarich, N. A., Kuhr, C. S., Doremus, C., Finn, E., Liggitt, D., et al. (2009) · Molecular Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 40
- Verified
Surrogate gene therapy for muscular dystrophy
Davies, K. E., & Chamberlain, J. S. (2019) · Nature Medicine
Muscle Physiology and DisordersVirus-based gene therapy research
Cited by 11
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free